NACDS continues to advocate in anticipation of the House and Senate conference on S. 524, the Comprehensive Addiction and Recovery Act (CARA). The legislation would adjust existing authorizations and programs to provide a series of resources and incentives to help healthcare providers, law enforcement officials and state and local governments to expand drug treatment, prevention and recovery efforts.

The House version does not contain the provision in the Senate legislation that requires pharmacists to check their prescription drug monitoring programs (PDMPs) before filling every prescription for a controlled substance to be eligible for federal grant funding.  NACDS RxIMPACT launched a grasstops campaign this week encouraging NACDS member companies with store operations represented by 46 House and 20 Senate leaders to build support for the House position in the conference.